Raras
Buscar doenças, sintomas, genes...
Distonia-parkinsonismo de início agudo
ORPHA:71517CID-10 · G24.1CID-11 · 8A02.12OMIM 128235PCDT · SUSDOENÇA RARA

Distonia-parkinsonismo de início rápido (RDP) é um distúrbio de movimento muito raro, caracterizado pelo início súbito de parkinsonismo e distonia, muitas vezes desencadeado por estresse físico ou psicológico.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distonia-parkinsonismo de início rápido (RDP) é um distúrbio de movimento muito raro, caracterizado pelo início súbito de parkinsonismo e distonia, muitas vezes desencadeado por estresse físico ou psicológico.

Pesquisas ativas
2 ensaios
5 total registrados no ClinicalTrials.gov
Publicações científicas
192 artigos
Último publicado: 2026 Mar 24

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
100
pacientes catalogados
Início
Adolescent
+ adult, childhood
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G24.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
9 sintomas
💪
Músculos
3 sintomas
🫃
Digestivo
1 sintomas
😀
Face
1 sintomas

+ 15 sintomas em outras categorias

Características mais comuns

73%prev.
Sinais bulbares
Frequência: 8/11
72%prev.
Anomalia do desenvolvimento do giro frontal inferior
Frequência: 13/18
55%prev.
Distonia craniofacial
Frequente (79-30%)
55%prev.
Sialorreia
Frequente (79-30%)
55%prev.
Atraso motor
Frequente (79-30%)
55%prev.
Bradicinesia
Frequente (79-30%)
29sintomas
Frequente (16)
Ocasional (8)
Muito raro (1)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 29 características clínicas mais associadas, ordenadas por frequência.

Sinais bulbaresBulbar signs
Frequência: 8/1173%
Anomalia do desenvolvimento do giro frontal inferiorHP:0011462
Frequência: 13/1872%
Distonia craniofacialCraniofacial dystonia
Frequente (79-30%)55%
SialorreiaDrooling
Frequente (79-30%)55%
Atraso motorMotor delay
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico192PubMed
Últimos 10 anos114publicações
Pico202117 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637

Variantes genéticas (ClinVar)

383 variantes patogênicas registradas no ClinVar.

🧬 ATP1A3: NM_152296.5(ATP1A3):c.974G>T (p.Gly325Val) ()
🧬 ATP1A3: NM_152296.5(ATP1A3):c.6+1G>A ()
🧬 ATP1A3: NM_152296.5(ATP1A3):c.1171G>A (p.Asp391Asn) ()
🧬 ATP1A3: NM_152296.5(ATP1A3):c.1106G>T (p.Gly369Val) ()
🧬 ATP1A3: NM_152296.5(ATP1A3):c.2977G>T (p.Glu993Ter) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distonia-parkinsonismo de início agudo

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

5 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
115 papers (10 anos)
#1

Pathogenic Variants in the PRKRA Gene Can Result in a Rapid-Onset Dystonia-Parkinsonism-like Phenotype.

Movement disorders : official journal of the Movement Disorder Society2026 Mar 24
#2

Network mechanisms in rapid-onset dystonia-parkinsonism.

Experimental neurology2025 Oct 03

Rapid-onset dystonia-parkinsonism (RDP) is a rare neurological disorder caused by mutations in the ATP1A3 gene. Symptoms are characterized by a dystonia-parkinsonism. Recently, experimental studies have shown that the pathophysiology of the disease is based on a combined dysfunction of the cerebellum (CB) and basal ganglia (BG) and that blocking their interaction can alleviate the symptoms. The underlying network mechanisms have not been studied so far. Our aim was to characterize neuronal network activity in the BG and CB and motor cortex in the ouabain model of RDP by site-specific infusion of ouabain. Rats were chronically infused with ouabain either in the CB, striatum (STR) or at both places simultaneously. Motor behavior was scored using published rating systems. Parallel in vivo recordings of local field potentials (LFP) from M1, deep cerebellar nuclei (DCN) and substantia nigra reticulata (SNr) were performed. Data were compared to untreated controls. Ouabain infusion into the cerebellum produced severe dystonia that was associated with increased high-frequency gamma oscillations in the DCNs, which were subsequently transmitted to the BG and M1. Striatal infusion led to parkinsonism and elevated beta-oscillations in SNr that were transmitted to the CB and M1. The simultaneous application of STRs and CB with ouabain resulted in dystonia-parkinsonism and increased beta oscillations in BG, CB, and M1. We demonstrate that symptom-specific beta and gamma oscillations can be transmitted between the BG and CB, which is likely to be very important for the understanding of disease mechanisms.

#3

ATP1A3 dysfunction causes motor hyperexcitability and afterhyperpolarization loss in a dystonia model.

Brain : a journal of neurology2025 Apr 03

Mutations in the gene encoding the alpha3 Na+/K+-ATPase isoform (ATP1A3) lead to movement disorders that manifest with dystonia, a common neurological symptom with many different origins, but for which the underlying molecular mechanisms remain poorly understood. We have generated an ATP1A3 mutant mouse that displays motor impairments and a hyperexcitable motor phenotype compatible with dystonia. We show that neurons harbouring this mutation are compromised in their ability to extrude raised levels of intracellular sodium, highlighting a profound deficit in neuronal sodium homeostasis. We show that the spinal motor network in ATP1A3 mutant mice has a reduced responsiveness to activity-dependent rises in intracellular sodium and that this is accompanied by loss of the Na+/K+-ATPase-mediated afterhyperpolarization in motor neurons. Taken together, our data support that the alpha3 Na+/K+-ATPase is important for cellular and spinal motor network homeostasis. These insights suggest that it may be useful to consider ways to compensate for this loss of a critical afterhyperpolarization-dependent control of neuronal excitability when developing future therapies for dystonia.

#4

CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.

Molecular syndromology2025 Nov 27

ATP1A3-related disorders encompass a clinically heterogeneous spectrum that includes previously defined dominantly inherited phenotypes such as alternating hemiplegia of childhood (AHC), rapid-onset dystonia-parkinsonism, and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome, as well as more complex and overlapping presentations. In this study, we present 2 pediatric cases that expand the phenotypic and genotypic spectrum of ATP1A3-associated disease. Both patients presented with "Guillain-Barré syndrome (GBS)-like episodes" characterized by acute-onset encephalopathy, ataxia, areflexia, and sensorimotor deterioration following febrile infections. Prominent paroxysmal postural abnormalities and dystonia were noted in both cases; however, the overall clinical features blurred the classical boundaries between CAPOS and other ATP1A3-associated phenotypes. The first patient carried the previously reported heterozygous ATP1A3(NM_001256214.2):c.2491G>A(p.Glu831Lys) variant, classically associated with CAPOS, and also exhibited sensorineural hearing loss with a positive family history. The second patient harbored a novel ATP1A3(NM_152296.5):c.2266C>T p.(Arg756Cys)(Clinvar: VCV000425189.38) variant and displayed oculomotor apraxia and chorea during episodes. These cases underscore the importance of considering ATP1A3 variants in children presenting with GBS-like features, infection-triggered neurological attacks, and mixed movement disorders. Our findings highlight the diagnostic value of genetic testing in atypical neuroregression syndromes and contribute to the recognition of "blended" ATP1A3 phenotypes beyond classical diagnostic entities. The novel pathogenic variant further supports ongoing efforts to refine genotype-phenotype correlations within this evolving group of neurological disorders. Some children develop sudden weakness and problems with balance and movement after having a fever. One reason for these symptoms can be rare changes in a gene called ATP1A3, which helps brain cells work by controlling salt movement in and out of the cells. Changes in this gene can cause a rare condition called cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome, which affects balance, hearing, and movement. In this report, we describe two young children in Turkey who had sudden weakness, balance problems, and unusual movements after infections. One child had a known gene change linked to CAPOS and had family members with hearing loss. The other child had a new gene change not reported before in Turkey and developed jerky movements (also called chorea). Both children improved with a medicine used for movement problems, which is not commonly used for these conditions but helped reduce their symptoms. Our report suggests that doctors should consider changes in the ATP1A3 gene when children develop weakness and movement problems after a fever. Finding these gene changes can help doctors choose better treatments and plan care for these children. It also shows that infections, including COVID-19, may trigger symptoms in children with changes in this gene. Learning more about these rare conditions can help improve care and understanding for children who suddenly develop these neurological problems.

#5

Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society2025 Nov

Previously, we identified decreased thalamic blood flow in patients with ATP1A3 variants. This study evaluated structural gray matter organization in rapid-onset dystonia-parkinsonism (RDP) patients compared with controls and two phenotypically overlapping movement disorders. Structural magnetic resonance imaging data were examined for whole-brain gray matter volume (GMV) abnormalities in 17 RDP patients, 20 isolated dystonia patients, 20 Parkinson's disease (PD) patients, and 20 controls. Left prefrontal cortical volume was increased in the RDP group in all comparisons. RDP patients showed additional bilateral volumetric increases in the right inferior temporal cortex and fusiform gyrus compared with controls, GMV changes in the inferior parietal cortex and thalamus compared with dystonia, and in the cerebellum compared with PD. Negative correlations between RDP duration and GMV were found in the right prefrontal cortex and bilateral caudate nucleus. Our data suggest that structural alterations in RDP involve sensorimotor and executive brain regions. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC80 artigos no totalmostrando 114

2026

Pathogenic Variants in the PRKRA Gene Can Result in a Rapid-Onset Dystonia-Parkinsonism-like Phenotype.

Movement disorders : official journal of the Movement Disorder Society
2025

CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.

Molecular syndromology
2025

Network mechanisms in rapid-onset dystonia-parkinsonism.

Experimental neurology
2025

Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society
2025

Rapid-onset dystonia-parkinsonism: First African case of ATP1A3 mutation.

Parkinsonism &amp; related disorders
2025

Not So Smooth Sailing: FIG4-Related Disease Is a Differential Diagnosis of Rapid Onset Dystonia-Parkinsonism.

Movement disorders clinical practice
2025

Neurological and psychiatric characterization of rapid-onset dystonia-parkinsonism over time.

Parkinsonism &amp; related disorders
2025

ATP1A3 dysfunction causes motor hyperexcitability and afterhyperpolarization loss in a dystonia model.

Brain : a journal of neurology
2024

In vitro study of ATP1A3 p.Ala275Pro mutant causing alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism.

Frontiers in neuroscience
2024

Phenotype Distinctions in Mice Deficient in the Neuron-Specific α3 Subunit of Na,K-ATPase: Atp1a3tm1Ling/+ and Atp1a3 +/D801Y.

eNeuro
2024

Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review.

Rambam Maimonides medical journal
2024

Letter of response to "concerns about efficacy of deep brain stimulation (DBS) in centromedian-parafascicular thalamic complex for rapid onset dystonia-parkinsonism (DYT12-ATP1A3)".

Brain stimulation
2024

Concerns about efficacy of deep brain stimulation (DBS) in centromedian-parafascicular thalamic complex for rapid onset dystonia-parkinsonism (DYT12-ATP1A3).

Brain stimulation
2024

The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis.

Journal of the neurological sciences
2023

ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle.

Parkinsonism &amp; related disorders
2023

Centromedian-parafascicular complex deep brain stimulation improves motor symptoms in rapid onset Dystonia-Parkinsonism (DYT12-ATP1A3).

Brain stimulation
2023

Rapid-Onset Dystonia and Parkinsonism in a Patient With Gaucher Disease.

Journal of movement disorders
2023

Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3.

Epileptic disorders : international epilepsy journal with videotape
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

Rapid-onset dystonia-parkinsonism is associated with reduced cerebral blood flow without gray matter changes.

Frontiers in neurology
2022

ATP1A3-Related Relapsing Encephalopathy with Cerebellar Ataxia (RECA): A Genetic Disorder with an Inflammatory Basis?

Movement disorders clinical practice
2022

The Phenotypic Continuum of ATP1A3-Related Disorders.

Neurology
2023

ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: A case report.

Brain &amp; development
2022

ATP1A3 mutation in rapid-onset dystonia parkinsonism: New data and genotype-phenotype correlation analysis.

Frontiers in aging neuroscience
2022

Molecular and clinical characteristics of ATP1A3-related diseases.

Frontiers in neurology
2022

Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: A narrative review.

Medicine
2022

Hemidystonia with polymicrogyria is part of ATP1A3-related disorders.

Brain &amp; development
2022

Teaching Video NeuroImage: Oculogyric Crises in a 12-Year-Old Girl With Rapid-Onset Dystonia Parkinsonism.

Neurology
2022

Chinese patients with p.Arg756 mutations of ATP1A3: Clinical manifestations, treatment, and follow-up.

Pediatric investigation
2022

A novel presentation of an ATP1A3 gene mutation - case report and literature review.

European review for medical and pharmacological sciences
2022

In Vivo Brain Sodium Disequilibrium in ATP1A3-Related Rapid-Onset Dystonia-Parkinsonism.

Movement disorders : official journal of the Movement Disorder Society
2021

A Rare Cause of Recurrent Febrile Encephalopathy in a Child: The Expanding Spectrum of ATP1A3 Mutations.

Cureus
2022

Different phenotypes of neurological diseases, including alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism, caused by de novo ATP1A3 mutation in a family.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Long-Term Follow-Up of a Patient with a De Novo p.Arg769Cys Mutation in the ATP1A3 Gene.

Movement disorders clinical practice
2021

Expanding Phenotype of ATP1A3 - Related Disorders: A Case Series.

Child neurology open
2021

The diagnostic spectrum of ATP1A3-related disorders: 3 new patients.

Journal of the neurological sciences
2021

Genetically altered animal models for ATP1A3-related disorders.

Disease models &amp; mechanisms
2021

ATP1A3-related disorders in the differential diagnosis of acute brainstem and cerebellar dysfunction.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

Atypical presentation of rapid-onset dystonia-parkinsonism in a toddler with a novel mutation in the ATP1A3 gene.

BMJ case reports
2021

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes.

International journal of molecular sciences
2021

Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.

Molecular genetics &amp; genomic medicine
2021

Understanding Psychiatric Disorders in Idiopathic and Inherited (Monogenic) Forms of Isolated and Combined Dystonia: A Systematic Review.

The Journal of neuropsychiatry and clinical neurosciences
2021

Rapid-Onset Dystonia-Parkinsonism Phenotype Consistency for a Novel Variant of ATP1A3 in Patients Across 3 Global Populations.

Neurology. Genetics
2021

ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.

Brain : a journal of neurology
2021

ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.

Frontiers in neurology
2021

Anesthetic Management of a Child With Rapid-Onset Dystonia-Parkinsonism (DYT12-ATP1A3): A Case Report.

A&amp;A practice
2021

De novo ATP1A3 variants cause polymicrogyria.

Science advances
2021

Rapid-onset dystonia-parkinsonism with ATP1A3 mutation and left lower limb paroxysmal dystonia.

Brain &amp; development
2020

The Expanding Phenotypic Spectrums Associated with ATP1A3 Mutation in a Family with Rapid-Onset Dystonia Parkinsonism.

Neuro-degenerative diseases
2020

Auditory-perceptual voice and speech evaluation in ATP1A3 positive patients.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2021

Combined dystonias: clinical and genetic updates.

Journal of neural transmission (Vienna, Austria : 1996)
2020

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia.

Journal of visualized experiments : JoVE
2020

Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study.

Neurology
2020

Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity.

Neurobiology of disease
2020

Mutational and phenotypic expansion of ATP1A3-related disorders: Report of nine cases.

Gene
2020

Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations.

The application of clinical genetics
2020

Epileptic encephalopathy with features of rapid-onset dystonia Parkinsonism and alternating hemiplegia of childhood: a novel combination phenotype associated with ATP1A3 mutation.

Epileptic disorders : international epilepsy journal with videotape
2020

ATP1A3-related epilepsy: Report of seven cases and literature-based analysis of treatment response.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2020

Clinical and Genetic Spectrum of ATP1A3-Related Disorders in a Korean Pediatric Population.

Journal of clinical neurology (Seoul, Korea)
2020

Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism.

Experimental neurology
2019

Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.

Neurobiology of disease
2019

Fever-related ataxia: a case report of CAPOS syndrome.

Cerebellum &amp; ataxias
2019

Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.

Movement disorders : official journal of the Movement Disorder Society
2019

Bipolar Disorder in a Young Woman With Preexisting Rapid-Onset Dystonia-Parkinsonism and Successful Treatment With Clozapine and Lithium.

Journal of clinical psychopharmacology
2019

Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2019

Automatic Segmentation of the Subthalamic Nucleus: A Viable Option to Support Planning and Visualization of Patient-Specific Targeting in Deep Brain Stimulation.

Operative neurosurgery (Hagerstown, Md.)
2018

Atypical Presentation of Rapid-onset Dystonia-parkinsonism (DYT12) Unresponsive to Deep Brain Stimulation of the Subthalamic Nucleus.

Movement disorders clinical practice
2020

Cell biology and dynamics of Neuronal Na+/K+-ATPase in health and diseases.

Neuropharmacology
2019

A case of early onset life-threatening epilepsy associated with a novel ATP1A3 gene variant.

Brain &amp; development
2018

Rapid-onset dystonia-parkinsonism preceded by a single episode of subacute persisting hemiparesis: Expanding the ATP1A3-related disorders phenotype.

Journal of the neurological sciences
2018

Early Life Epilepsy and Episodic Apnea Revealing an ATP1A3 Mutation: Report of a Pediatric Case and Literature Review.

Neuropediatrics
2018

An Elderly Woman with Reversal of Clinical Presentation Mimicking Rapid-Onset Dystonia-Parkinsonism.

Journal of clinical neurology (Seoul, Korea)
2018

De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome.

Molecular genetics and metabolism reports
2018

Variants in the ATP1A3 Gene Mutations within Severe Apnea Starting in Early Infancy: An Observational Study of Two Cases with a Possible Relation to Epileptic Activity.

Neuropediatrics
2018

Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations.

Cerebellum (London, England)
2018

ATP1A3 spectrum disorders: A video-documented history of 7 genetically confirmed early onset cases.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

ATP1A3-related disorders: An update.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid-Onset Dystonia-Parkinsonism (DYT12).

Movement disorders clinical practice
2017

Disruption of Ankyrin B and Caveolin-1 Interaction Sites Alters Na+,K+-ATPase Membrane Diffusion.

Biophysical journal
2017

It's not just the basal ganglia: Cerebellum as a target for dystonia therapeutics.

Movement disorders : official journal of the Movement Disorder Society
2017

Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.

Pediatric neurology
2017

[Dystonia 12: A rare and difficult diagnosis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2017

A Portuguese rapid-onset dystonia-parkinsonism case with atypical features.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2017

Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump.

PLoS genetics
2017

[A childhood-onset rapid-onset dystonia parkinsonism family with ATP1A3 gene mutation and literatures review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2017

Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders.

Neurology. Genetics
2017

A novel de-novo mutation in the ATP1A3 gene causing rapid-onset dystonia parkinsonism.

Parkinsonism &amp; related disorders
2017

Sodium Pumps Mediate Activity-Dependent Changes in Mammalian Motor Networks.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2016

A case of rapid-onset dystonia-parkinsonism accompanied by pyramidal tract impairment.

BMC neurology
2017

Mosaicism in ATP1A3-related disorders: not just a theoretical risk.

Neurogenetics
2016

De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis.

BMC neurology
2016

A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.

Cold Spring Harbor molecular case studies
2016

Neurological disease mutations of α3 Na+,K+-ATPase: Structural and functional perspectives and rescue of compromised function.

Biochimica et biophysica acta
2016

Cognitive deficits caused by a disease-mutation in the α3 Na(+)/K(+)-ATPase isoform.

Scientific reports
2016

Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.

Frontiers in physiology
2016

The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.

Frontiers in physiology
2016

Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood.

Journal of neurogenetics
2016

Childhood-onset ATP1A3-related conditions: Report of two new cases of phenotypic spectrum.

Parkinsonism &amp; related disorders
2016

Basal Ganglia Gliosis in a Case of Rapid-Onset Dystonia-Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3).

Movement disorders clinical practice
2016

Managing Brain Extracellular K(+) during Neuronal Activity: The Physiological Role of the Na(+)/K(+)-ATPase Subunit Isoforms.

Frontiers in physiology
2016

ATP1A3 Mutation in Adult Rapid-Onset Ataxia.

PloS one
2016

Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations.

Movement disorders clinical practice
2016

A Distinct Phenotype in a Novel ATP1A3 Mutation: Connecting the Two Ends of a Spectrum.

Movement disorders clinical practice
2015

Intermediate Phenotypes of ATP1A3 Mutations: Phenotype-Genotype Correlations.

Tremor and other hyperkinetic movements (New York, N.Y.)
2015

Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.

Developmental medicine and child neurology
2015

α-synuclein assemblies sequester neuronal α3-Na+/K+-ATPase and impair Na+ gradient.

The EMBO journal
2015

Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism.

Neurobiology of disease
2015

CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 Gene.

Journal of child neurology
2015

Neuronal Na+/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome.

Neurology
2015

Subacute sclerosing panencephalitis masquerading as rapid-onset dystonia-Parkinsonism in a child.

Neurology India
2015

Rescue of Na+ affinity in aspartate 928 mutants of Na+,K+-ATPase by secondary mutation of glutamate 314.

The Journal of biological chemistry
2015

Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly.

Epilepsia
2015

Isolated and combined dystonia syndromes - an update on new genes and their phenotypes.

European journal of neurology
2016

P2C-Type ATPases and Their Regulation.

Molecular neurobiology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distonia-parkinsonismo de início agudo.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distonia-parkinsonismo de início agudo

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Pathogenic Variants in the PRKRA Gene Can Result in a Rapid-Onset Dystonia-Parkinsonism-like Phenotype.
    Movement disorders : official journal of the Movement Disorder Society· 2026· PMID 41873774mais citado
  2. Network mechanisms in rapid-onset dystonia-parkinsonism.
    Experimental neurology· 2025· PMID 41047113mais citado
  3. ATP1A3 dysfunction causes motor hyperexcitability and afterhyperpolarization loss in a dystonia model.
    Brain : a journal of neurology· 2025· PMID 39533828mais citado
  4. CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.
    Molecular syndromology· 2025· PMID 41480049mais citado
  5. Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society· 2025· PMID 40888012mais citado
  6. Rapid-onset dystonia-parkinsonism: First African case of ATP1A3 mutation.
    Parkinsonism Relat Disord· 2025· PMID 40752381recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:71517(Orphanet)
  2. OMIM OMIM:128235(OMIM)
  3. MONDO:0007496(MONDO)
  4. Distonia e Espasticidade(PCDT · Ministério da Saúde)
  5. GARD:9628(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Q32038818(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distonia-parkinsonismo de início agudo
Compêndio · Raras BR

Distonia-parkinsonismo de início agudo

ORPHA:71517 · MONDO:0007496
🇧🇷 Brasil SUS
Geral
Prevalência
<1 / 1 000 000
Casos
100 casos conhecidos
Herança
Autosomal dominant, Not applicable
CID-10
G24.1 · Distonia familiar idiopática
CID-11
Ensaios
2 ativos
Início
Adolescent, Adult, Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1868681
Repurposing
2 candidatos
procyclidineacetylcholine receptor antagonist
trihexyphenidyl
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades